We demonstrated in this study that 17β-estradiol increases CD3+CD69+ and CD3+IFNγ+ T cells in SLE patients and that 17β-estradiol treatment increases secreted IFNγ protein levels in healthy control PBMCs. The gene discussed is CD69; the disease is systemic lupus erythematosus.